Leukemia drug nilotinib safe, shows promise against Alzheimer's disease in trial

Thursday, May 28, 2020 - 23:30 in Health & Medicine

The leukemia drug nilotinib, which shows promise in reducing the effects of Alzheimer's disease, is safe and has minimal side effects when used at low doses, according to a small clinical trial published Friday.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net